- Oral cancer drugs taken at home generally fall under Part D, while drugs infused or injected in a clinic generally fall under Part B.
- In 2026, covered Part D drug costs are capped at $2,100 out of pocket, then $0 for covered drugs for the rest of the year.
- Antineoplastics are a protected Part D class, but tier, prior authorization, and specialty-pharmacy rules still affect access and cost.
If you take a cancer drug in pill form at home, will Medicare Part D cover it — and what will you pay? In many cases, yes, but the answer depends on how the drug is given, whether your plan lists it, and which tier your plan puts it on. The distinction between Part D and Part B matters first, because it decides which benefit — and which cost rules — apply.
Part D vs. Part B: it depends on how the drug is given
Medicare does not sort cancer drugs by diagnosis alone. As a general rule:
- Part D covers prescription drugs you take yourself at home, including many oral chemotherapy drugs, targeted therapies, and hormone therapies, when they are on your plan's formulary.
- Part B generally covers drugs administered in a doctor's office, clinic, or hospital outpatient setting, such as infused chemotherapy and immunotherapy, along with radiation and related services.
Some drugs can fall on either side depending on form and setting, so confirm which part your plan and prescriber expect to cover your specific prescription.
The protected class: antineoplastics
Part D plans each publish a formulary, a list of covered drugs organized into tiers. Federal rules require every formulary to include at least two chemically distinct drugs in each therapeutic category and class. For six "protected" classes, the rule is stricter: plans must cover all or substantially all drugs in the class.
Antineoplastics — the class that includes many cancer drugs — are one of those protected classes, because cancer treatments are not easily interchangeable. That does not mean every cancer drug is covered without conditions, or at a low price: a plan can still place a drug on a higher tier and apply prior authorization, a quantity limit, or step therapy.
What you pay in 2026
Most oral cancer drugs sit on a plan's specialty tier, the highest tier, where cost-sharing is usually coinsurance — a percentage of the drug's cost — rather than a flat copayment. That can mean a large bill at the pharmacy early in the year, even though the annual picture is now capped. In 2026, the standard structure works like this:
- The maximum standard deductible is $615. Some plans charge less, or $0 for certain tiers.
- After the deductible, you generally pay a copayment or coinsurance until your total out-of-pocket spending on covered drugs reaches $2,100.
- Once you reach $2,100, you pay $0 for covered Part D drugs for the rest of the calendar year.
- The coverage gap known as the "donut hole" was eliminated in 2025, so there is no separate gap phase to plan around.
- Your monthly premium does not count toward the $2,100 cap, and neither do drugs that are not covered by your plan.
Because specialty drugs are expensive, many people taking oral cancer drugs reach the cap early in the year. If a large early bill is the problem, the Medicare Prescription Payment Plan may help by spreading out-of-pocket costs across monthly payments; it does not lower your total cost. People with limited income may also qualify for Extra Help, which lowers premiums, deductibles, and copayments.
How to check your drug before you enroll or refill
Do not choose a plan on premium alone, and do not assume a protected-class drug is affordable at your pharmacy. Before enrollment or a refill, check:
- Search your plan's formulary for your exact drug, dose, and form.
- Note the tier — specialty-tier drugs usually mean higher cost-sharing before you reach the cap.
- Check for restrictions such as prior authorization, step therapy, or a quantity limit.
- Confirm the pharmacy — many specialty drugs must go through a plan-designated specialty pharmacy, which may ship the drug rather than stocking it at a local counter.
- Compare plans on Medicare Plan Finder using your full medication list, not just your premium, during the Annual Enrollment Period, October 15 through December 7.
If a new plan does not cover a drug you were already taking, or adds a restriction, ask about a transition fill — a one-time, temporary supply while you pursue an exception or alternative.
If your drug is denied or restricted
A denial is not necessarily the end of the story. You or your prescriber can request a coverage determination, including a formulary exception asking the plan to cover the drug or waive a restriction. Your prescriber usually needs to submit a supporting statement explaining why the plan's preferred alternatives would not work as well or could cause harm.
If the exception is denied, you can appeal, starting with a redetermination by the plan. Keep copies of every letter, note the date of every call, and start promptly — do not wait until you run out of medication. Free help is also available from your State Health Insurance Assistance Program (SHIP). This article is educational only, not medical or insurance advice.
Bottom line: Part D generally covers oral cancer drugs taken at home, with antineoplastics protected as a class and 2026 out-of-pocket costs capped at $2,100, but your exact cost depends on your plan's tier and rules — so check your drug by name, confirm the pharmacy, and appeal promptly if it is denied.